**Core Concept:**
Angiotensin converting enzyme inhibitors (ACEIs), diuretics, and calcium channel blockers are medications used to lower blood pressure. Beta blockers are also used to lower blood pressure, but they have the added benefit of reducing the risk of heart attack and stroke in high-risk patients. Emphysema is a chronic obstructive pulmonary disease (COPD) characterized by airflow limitation and air trapping due to destruction of lung parenchyma and loss of elasticity.

**Why the Correct Answer is Right:**
In this patient with COPD, the physician has tried multiple antihypertensive agents but had to discontinue them due to side effects. Since the patient is already suffering from a respiratory disorder (COPD), it is essential to choose a medication that does not worsen respiratory symptoms or cause further complications. Beta blockers are suitable for this patient, as they do not worsen respiratory symptoms like dyspnoea or wheezing, which is common in patients with COPD. Additionally, beta blockers can reduce the risk of heart attack and stroke in high-risk patients, which is crucial for a patient with underlying cardiovascular risk due to COPD.

**Why Each Wrong Option is Incorrect:**

A. Angiotensin converting enzyme inhibitors (ACEIs): These medications are effective in lowering blood pressure, but they can worsen respiratory symptoms in patients with COPD due to their bronchoconstrictor effect.

B. Diuretics: Although diuretics are effective in lowering blood pressure, they can exacerbate respiratory symptoms in patients with COPD by worsening respiratory alkalosis and dehydration, which can lead to exacerbations of respiratory symptoms.

C. Calcium channel blockers: Similar to ACEIs, calcium channel blockers can cause bronchoconstriction in patients with COPD, leading to worsening of respiratory symptoms.

D. Beta blockers: As mentioned before, beta blockers are suitable for this patient as they do not worsen respiratory symptoms and can reduce the risk of heart attack and stroke in high-risk patients.

**Clinical Pearl:**
In patients with COPD and hypertension, beta blockers are the preferred choice among the antihypertensive medications due to their lack of adverse effects on respiratory function. Beta blockers can also provide additional benefits of reducing cardiovascular risk in these patients.